News Novo's once-daily haemophilia therapy scores FDA nod on second try - FirstWord Pharma

[FeedBot]

... and Pfizer's Beqvez/Durveqtix (fidanacogene elaparvovec). For more on the topic, read Spotlight On: KOLs find a new balance in haemophilia B.

Continue reading...